4694 — BML Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual income statement for BML, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	120,732	138,571	186,067	159,462	137,964
Cost of Revenue
Gross Profit	42,251	54,768	86,951	61,446	45,629
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	111,007	118,688	137,932	135,739	128,884
Operating Profit	9,725	19,883	48,135	23,723	9,080
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	10,175	21,002	50,328	24,184	9,523
Provision for Income Taxes
Net Income After Taxes	6,799	14,284	34,678	16,157	6,263
Minority Interest
Net Income Before Extraordinary Items
Net Income	6,376	13,712	33,741	15,579	6,035
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	6,375	13,711	33,741	15,578	6,034
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	152	338	845	399	156
Dividends per Share
Special Dividends per Share